Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
Author(s) -
Gauri R. Varadhachary,
Robert A. Wolff,
Christopher H. Crane,
Charlotte C. Sun,
Jeffrey E. Lee,
Peter W. T. Pisters,
JeanNicolas Vauthey,
Eddie K. Abdalla,
Huamin Wang,
Gregg Staerkel,
Jeffrey H. Lee,
William A. Ross,
Eric P. Tamm,
Priya Bhosale,
Sunil Krishnan,
Prajnan Das,
Linus Ho,
Henry Xiong,
James L. Abbruzzese,
Douglas B. Evans
Publication year - 2008
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2007.15.8642
Subject(s) - medicine , gemcitabine , pancreatic cancer , chemoradiotherapy , adenocarcinoma , cisplatin , chemotherapy , radiation therapy , stage (stratigraphy) , surgery , oncology , cancer , paleontology , biology
We conducted a phase II trial of preoperative gemcitabine and cisplatin chemotherapy in addition to chemoradiation (Gem-Cis-XRT) and pancreaticoduodenectomy (PD) for patients with stage I/II pancreatic adenocarcinoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom